V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330011117 | 330012310 | 0 | 52.2 | Palliative (P) | 2017-11-17 | 2018-05-29 | CNS LGG2004 03 vinc + carbo | N | N | 330000310 | NOT MATCHED |
| 330011118 | 330003005 | 0 | 15.7 | Curative (C) | 2018-05-21 | 2018-05-21 | NB Rel CCLG guidelines Irin & Temoz | 2 | N | 330000310 | NOT MATCHED |
| 330011119 | 330003006 | 0 | 37.8 | Neo-adjuvant (N) | 2017-08-07 | 2017-08-08 | NB HRNBL-1 COJEC Ind COURSE B | N | Y | 330000334 | NOT MATCHED |
| 330011120 | 330003008 | 1.74 | 21.8 | Neo-adjuvant (N) | 2016-03-25 | 2016-07-05 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + FILGRASTIM + METHOTREXATE | N | null | 330000353 | NOT MATCHED |
| 330011121 | 330012741 | 0 | 10.9 | Palliative (P) | 2017-10-08 | 2017-10-16 | BLEOMYCIN + CISPLATIN + PACLITAXEL | 01 | Y | 330000390 | NOT MATCHED |
| 330011122 | 330003016 | 0 | null | Neo-adjuvant (N) | 2016-10-26 | 2016-11-07 | NB BEACON Temozolomide alone | null | N | 330000391 | NOT MATCHED |
| 330011123 | 330003019 | null | 10.9 | Curative (C) | 2016-10-17 | 2017-09-30 | EW EuroEwing 2012 Arm B VC | N | N | 330000392 | NOT MATCHED |
| 330011124 | 330007613 | 1.74 | 55.1 | null | 2015-12-23 | 2016-01-22 | Cisplatin 100 + RT(H&N) 1 day | null | N | 330000394 | CISPLATIN + RT |
| 330011125 | 330003023 | 0 | 47.5 | Curative (C) | 2017-08-10 | 2017-08-10 | CNS LGG 2004 03 cons vinc + carbo | 01 | null | 330000397 | NOT MATCHED |
| 330011126 | 330003027 | null | 14.9 | Curative (C) | 2012-11-30 | 2015-03-30 | NB HRNBL-1 MOD N7 PE | Y | N | 330000410 | NOT MATCHED |
| 330011127 | 330003033 | null | 114 | Disease modification (D) | 2014-12-24 | 2015-10-16 | NB HRNBL-1 COJEC Ind COURSE B | Y | N | 330000450 | NOT MATCHED |
| 330011129 | 330003044 | null | 16.05 | Disease modification (D) | 2013-08-01 | 2013-08-01 | EW Rel rEECur Gemcitabine/Docetaxel | Y | null | 330000516 | NOT MATCHED |
| 330011130 | 330003051 | null | 57.4 | Curative (C) | 2015-06-01 | 2015-06-06 | Cisplatin + Radiotherapy | N | N | 330000539 | CISPLATIN + RT |
| 330011131 | 330003052 | 1.69 | 10.4 | Curative (C) | null | 2013-10-21 | NB HRNBL-1 COJEC Ind COURSE B | Y | N | 330000542 | NOT MATCHED |
| 330011132 | 330003058 | 1.6 | 16.2 | Curative (C) | 2017-02-13 | 2017-02-21 | NB HRNBL-1 Isotretinoin | Y | null | 330000589 | NOT MATCHED |
| 330011133 | 330003066 | 1.36 | 16.5 | Curative (C) | 2018-04-08 | 2018-04-29 | CNS LGG 2004 03 cons vinc + carbo | N | N | 330000642 | NOT MATCHED |
| 330011134 | 330003069 | 0 | 12 | Curative (C) | 2016-01-07 | 2016-01-17 | NB HRNBL-1 COJEC Ind COURSE B | N | N | 330000643 | NOT MATCHED |
| 330011135 | 330003071 | null | 8 | Adjuvant (A) | 2016-10-25 | 2016-10-29 | NB HRNBL-1 COJEC Ind COURSE B | 02 | N | 330000651 | NOT MATCHED |
| 330011136 | 330003073 | null | 15.6 | Palliative (P) | 2018-02-21 | 2018-02-21 | null | N | N | 330000652 | NOT MATCHED |
| 330011137 | 330003079 | 0 | 87.6 | Curative (C) | 2015-04-04 | 2015-04-04 | CNS LGG 2004 03 cons vinc + carbo | 01 | Y | 330000684 | NOT MATCHED |
| 330011138 | 330003081 | 0.88 | 16.3 | Disease modification (D) | 2015-07-27 | 2016-01-10 | NB HRNBL-1 BUMEL MAT | N | null | 330000686 | NOT MATCHED |
| 330011139 | 330003093 | 0 | 68.1 | Curative (C) | 2014-10-12 | 2015-03-07 | NB HRNBL-1 COJEC Ind COURSE C | N | null | 330000793 | NOT MATCHED |
| 330011140 | 330003099 | null | null | Adjuvant (A) | null | 2015-02-01 | CISPLATIN + RT | 2 | null | 330000855 | CISPLATIN + RT |
| 330011141 | 330003102 | 1.81 | null | Curative (C) | 2013-09-07 | 2013-09-24 | Cisplatin + Radiotherapy | 02 | Y | 330000867 | CISPLATIN + RT |
| 330011142 | 330007659 | 1.76 | null | Curative (C) | 2014-10-11 | 2014-10-11 | Cisplatin 100 + RT(H&N) 1 day | null | N | 330000884 | CISPLATIN + RT |
| 330011143 | 330003108 | 1.64 | 69.3 | Curative (C) | 2013-10-10 | 2013-10-15 | Cisplatin + Radiotherapy | 02 | null | 330000894 | CISPLATIN + RT |
| 330011144 | 330003114 | 1.67 | 55.4 | Curative (C) | 2015-03-01 | 2015-03-08 | CISPLATIN + RT | 02 | Y | 330000926 | CISPLATIN + RT |
| 330011145 | 330003123 | 1.9 | 64 | Curative (C) | 2014-07-10 | 2014-07-10 | Cisplatin 100 + RT(H&N) 1 day | N | null | 330000980 | CISPLATIN + RT |
| 330011146 | 330003130 | 1.98 | 85.9 | Curative (C) | 2015-03-02 | 2015-03-02 | Cisplatin + Radiotherapy | 02 | Y | 330001087 | CISPLATIN + RT |
| 330011147 | 330003138 | 1.72 | null | null | 2016-01-24 | 2016-04-10 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 330001117 | CISPLATIN + RT |
| 330011148 | 330007677 | 1.76 | 55.4 | Curative (C) | 2016-08-08 | 2016-12-11 | CISPLATIN + RT | N | Y | 330001166 | CISPLATIN + RT |
| 330011149 | 330003152 | null | 85 | Curative (C) | 2017-09-08 | 2018-04-15 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330001243 | CISPLATIN + RT |
| 330011150 | 330003167 | 1.74 | 123.5 | Curative (C) | 2019-01-02 | 2019-02-20 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 330001376 | CISPLATIN + RT |
| 330011151 | 330007693 | null | null | Curative (C) | null | 2018-04-16 | CISPLATIN + RT | null | N | 330001436 | CISPLATIN + RT |
| 330011152 | 330003177 | 1.08 | 11 | Palliative (P) | 2016-08-31 | 2016-08-31 | null | 01 | N | 330001442 | NOT MATCHED |
| 330011153 | 330003179 | 1.55 | null | Curative (C) | 2015-07-09 | 2015-08-05 | CISPLATIN + RT | null | null | 330001484 | CISPLATIN + RT |
| 330011154 | 330003183 | 1.73 | 71 | Adjuvant (A) | 2017-02-07 | 2017-03-01 | Cisplatin + Radiotherapy | 2 | Y | 330001547 | CISPLATIN + RT |
| 330011156 | 330010196 | null | 65.7 | Curative (C) | 2014-01-27 | 2014-01-27 | Cisplatin + Radiotherapy | 02 | Y | 330001554 | CISPLATIN + RT |
| 330011157 | 330003189 | 0.8 | 19.8 | Palliative (P) | 2014-05-26 | 2014-10-27 | CNS LGG2004 03 vinc + carbo | N | Y | 330001612 | NOT MATCHED |
| 330011158 | 330010201 | 0 | 8.5 | Curative (C) | 2016-02-01 | 2016-03-12 | CNS LGG | Y | Y | 330001765 | NOT MATCHED |
| 330011159 | 330003203 | 1.71 | 90.5 | Curative (C) | 2016-03-16 | 2016-03-16 | CISPLATIN + RT | null | N | 330001766 | CISPLATIN + RT |
| 330011160 | 330012325 | 0 | 46.7 | Curative (C) | null | 2016-04-05 | NB HRNBL-1 COJEC Ind COURSE C | N | null | 330001867 | NOT MATCHED |
| 330011161 | 330003221 | null | 18.1 | Palliative (P) | null | 2017-07-25 | NB HRNBL-1 COJEC Ind COURSE C | 02 | N | 330001925 | NOT MATCHED |
| 330011162 | 330003229 | 1.76 | 74.9 | Curative (C) | 2015-06-15 | 2015-07-15 | CISPLATIN + RT | 02 | Y | 330001965 | CISPLATIN + RT |
| 330011163 | 330003231 | 1.76 | 81.85 | Curative (C) | 2015-12-31 | 2016-04-28 | Cisplatin + Radiotherapy | N | N | 330001982 | CISPLATIN + RT |
| 330011164 | 330003237 | null | null | Curative (C) | null | 2013-12-15 | NB HRNBL-1 COJEC Ind COURSE B | null | Y | 330002000 | NOT MATCHED |
| 330011165 | 330003241 | null | 130.6 | Adjuvant (A) | 2017-11-12 | 2018-01-10 | Cisplatin 100 + RT(H&N) 1 day | null | Y | 330002029 | CISPLATIN + RT |
| 330011166 | 330003244 | 1.6 | 51.1 | null | 2017-04-21 | 2017-05-18 | LCHIV Cont A | N | N | 330002044 | NOT MATCHED |
| 330011167 | 330003250 | 0.92 | 14.8 | Palliative (P) | 2014-02-17 | 2015-03-23 | NB HRNBL-1 ch14.18/CHO only (trial) | N | N | 330002051 | NOT MATCHED |
| 330011168 | 330003252 | 1.75 | 13.2 | Neo-adjuvant (N) | 2014-07-07 | 2014-07-15 | NB HRNBL-1 COJEC Ind COURSE C | null | N | 330002063 | NOT MATCHED |